Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II chemoradiotherapy with S-1 and cisplatin for stage II/III esophageal carcinoma (JCOG0604)
jRCT2091220010Phase 2Completed
- Sponsor
- Japan Clinical Oncology Group
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur and cisplatin in esophageal cancer, sponsored by Japan Clinical Oncology Group. Primary endpoints: Incidence of dose limiting toxicity and Complete response rate. Started May 2007; status: completed.
02
Drugs
tegafurcisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCT2091220010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220010.